Team:Freiburg/Highlights
From 2013.igem.org
(Difference between revisions)
Lisaschmunk (Talk | contribs) |
Lisaschmunk (Talk | contribs) |
||
Line 293: | Line 293: | ||
Activation | Activation | ||
</p> | </p> | ||
- | <p>We fused dCas9 to the trans-activation domain VP16. This fusion protein is able to activate gene expression from a minimal CMV promoter. The fusion protein was successfully tested in mammalian cells and used to activate the secreted embryonic alkaline phosphatase (SEAP) reporter gene expression. We achieved over 25-fold upregulation of SEAP expression by targeting sequences located upstream of the promoter. | + | <p>We fused dCas9 to the trans-activation domain VP16. This fusion protein is able to activate gene expression from a minimal CMV promoter. The fusion protein was successfully tested in mammalian cells and used to activate the secreted embryonic alkaline phosphatase (SEAP) reporter gene expression. We achieved an over 25-fold upregulation of SEAP expression by targeting sequences located upstream of the promoter. Numbers characterizing the crRNAs in the graph represent the distance from the translation start site. <a id="link" href="https://2013.igem.org/Team:Freiburg/Project/effector#activation">Read more!</a></p> |
Revision as of 09:20, 19 October 2013
HIGHLIGHTS